The Role of MiR-34c-5p in Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells

Overview

Journal Int J Stem Cells

Date 2021 Apr 28

PMID 33906980

Citations 4

Authors

Bin Liu

Wei Gan

Zhang Jin

Meng Wang

Guopeng Cui

Hongyu Zhang

Huafu Wang

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) plays a critical role in the success of lumbar spinal fusion with autogenous bone graft. This study aims to explore the role and specific mechanism of miR-34c-5p in osteogenic differentiation of BMSCs.

Methods And Results: Rabbit model of lumbar fusion was established by surgery. The osteogenic differentiation dataset of mesenchymal stem cells was obtained from the Gene Expression Omnibus (GEO) database, and differentially expressed miRNAs were analyzed using R language (limma package). The expressions of miR-34c-5p, miR-199a-5p, miR-324-5p, miR-361-5p, RUNX2, OCN and Bcl-2 were determined by qRT-PCR and Western blot. ELISA, Alizarin red staining and CCK-8 were used to detect the ALP content, calcium deposition and proliferation of BMSCs. The targeted binding sites between miR-34c-5p and Bcl-2 were predicted by the Target database and verified using dual-luciferase reporter assay. MiR-34c-5p expression was higher in rabbit lumbar fusion model and differentiated BMSCs than normal rabbit or BMSCs. The content of ALP and the deposition of calcium increased with the osteogenic differentiation of BMSCs. Upregulation of miR-34c-5p reduced cell proliferation and promoted ALP content, calcium deposition, RUNX2 and OCN expression compared with the control group. The effects of miR-34c-5p inhibitor were the opposite. In addition, miR-34c-5p negatively correlated with Bcl-2. Upregulation of Bcl-2 reversed the effects of miR-34c-5p on ALP content, calcium deposition, and the expressions of RUNX2 and OCN.

Conclusions: miR-34c-5p could promote osteogenic differentiation and suppress proliferation of BMSCs by inhibiting Bcl-2.

Citing Articles

Role of mir-32-3p in the diagnosis and risk assessment of osteoporotic fractures.

Zhang J, Qian T, Zheng X, Qin H J Orthop Surg Res. 2024; 19(1):709.

PMID: 39487541 PMC: 11531180. DOI: 10.1186/s13018-024-05206-9.

Identification of the miRNA-mRNA regulatory network in a mouse model of early fracture.

Wang M, Xie Z, Yan K, Qiao C, Yan S, Wu G Front Genet. 2024; 15:1408404.

PMID: 38919952 PMC: 11196604. DOI: 10.3389/fgene.2024.1408404.

The Emerging Role of Non-Coding RNAs in Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells.

Chen X, Xie W, Zhang M, Shi Y, Xu S, Cheng H Front Cell Dev Biol. 2022; 10:903278.

PMID: 35652090 PMC: 9150698. DOI: 10.3389/fcell.2022.903278.

CircPTCH1 Promotes Migration in Lung Cancer by Regulating MYCN Expression Through miR-34c-5p.

Shen Z, Sun S Onco Targets Ther. 2021; 14:4779-4789.

PMID: 34531664 PMC: 8439975. DOI: 10.2147/OTT.S324015.

References

Schnake K, Rappert D, Storzer B, Schreyer S, Hilber F, Mehren C . [Lumbar fusion-Indications and techniques]. Orthopade. 2018; 48(1):50-58. DOI: 10.1007/s00132-018-03670-w. View

Ma J, Wang Z, Zhao J, Miao W, Ye T, Chen A . Resveratrol Attenuates Lipopolysaccharides (LPS)-Induced Inhibition of Osteoblast Differentiation in MC3T3-E1 Cells. Med Sci Monit. 2018; 24:2045-2052. PMC: 5903312. DOI: 10.12659/msm.905703. View

Hagman Z, Larne O, Edsjo A, Bjartell A, Ehrnstrom R, Ulmert D . miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions. Int J Cancer. 2011; 127(12):2768-76. DOI: 10.1002/ijc.25269. View

Tamura M, Uyama M, Sugiyama Y, Sato M . Canonical Wnt signaling activates miR-34 expression during osteoblastic differentiation. Mol Med Rep. 2013; 8(6):1807-11. DOI: 10.3892/mmr.2013.1713. View

Jeong J, Choi J . Interrelationship of Runx2 and estrogen pathway in skeletal tissues. BMB Rep. 2011; 44(10):613-8. DOI: 10.5483/BMBRep.2011.44.10.613. View

Bruckheimer E, Cho S, Sarkiss M, Herrmann J, McDonnell T . The Bcl-2 gene family and apoptosis. Adv Biochem Eng Biotechnol. 1998; 62:75-105. DOI: 10.1007/BFb0102306. View

Krol J, Loedige I, Filipowicz W . The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010; 11(9):597-610. DOI: 10.1038/nrg2843. View

Gomez-Puerto M, Verhagen L, Braat A, Lam E, Coffer P, Lorenowicz M . Activation of autophagy by FOXO3 regulates redox homeostasis during osteogenic differentiation. Autophagy. 2016; 12(10):1804-1816. PMC: 5079670. DOI: 10.1080/15548627.2016.1203484. View

Heng B, Ye X, Liu Y, Dissanayaka W, Pan Cheung G, Zhang C . Effects of Recombinant Overexpression of Bcl2 on the Proliferation, Apoptosis, and Osteogenic/Odontogenic Differentiation Potential of Dental Pulp Stem Cells. J Endod. 2016; 42(4):575-83. DOI: 10.1016/j.joen.2016.01.013. View

10.

Hu Y, Yang Q, Wang L, Wang S, Sun F, Xu D . Knockdown of the oncogene lncRNA NEAT1 restores the availability of and improves the sensitivity to cisplatin in osteosarcoma. Biosci Rep. 2018; 38(3). PMC: 6435545. DOI: 10.1042/BSR20180375. View

11.

Manolagas S . Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000; 21(2):115-37. DOI: 10.1210/edrv.21.2.0395. View

12.

Chavda S, Levin L . Human Studies of Vertical and Horizontal Alveolar Ridge Augmentation Comparing Different Types of Bone Graft Materials: A Systematic Review. J Oral Implantol. 2017; 44(1):74-84. DOI: 10.1563/aaid-joi-D-17-00053. View

13.

Cheng F, Yang M, Yang R . MiRNA-365a-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation via targeting RUNX2. Eur Rev Med Pharmacol Sci. 2019; 23(18):7766-7774. DOI: 10.26355/eurrev_201909_18986. View

14.

Jordana F, Le Visage C, Weiss P . [Bone substitutes]. Med Sci (Paris). 2017; 33(1):60-65. DOI: 10.1051/medsci/20173301010. View

15.

Liu W, Pang R, Chiu P, Wong B, Lao K, Lee K . Sperm-borne microRNA-34c is required for the first cleavage division in mouse. Proc Natl Acad Sci U S A. 2011; 109(2):490-4. PMC: 3258645. DOI: 10.1073/pnas.1110368109. View

16.

Zhang Y, Xie R, Gordon J, LeBlanc K, Stein J, Lian J . Control of mesenchymal lineage progression by microRNAs targeting skeletal gene regulators Trps1 and Runx2. J Biol Chem. 2012; 287(26):21926-35. PMC: 3381153. DOI: 10.1074/jbc.M112.340398. View

17.

Nagase Y, Iwasawa M, Akiyama T, Kadono Y, Nakamura M, Oshima Y . Anti-apoptotic molecule Bcl-2 regulates the differentiation, activation, and survival of both osteoblasts and osteoclasts. J Biol Chem. 2009; 284(52):36659-36669. PMC: 2794780. DOI: 10.1074/jbc.M109.016915. View

18.

Chen R, Qiu H, Tong Y, Liao F, Hu X, Qiu Y . MiRNA-19a-3p alleviates the progression of osteoporosis by targeting HDAC4 to promote the osteogenic differentiation of hMSCs. Biochem Biophys Res Commun. 2019; 516(3):666-672. DOI: 10.1016/j.bbrc.2019.06.083. View

19.

Lu T, Rothenberg M . MicroRNA. J Allergy Clin Immunol. 2017; 141(4):1202-1207. PMC: 5889965. DOI: 10.1016/j.jaci.2017.08.034. View

20.

Park D, Spencer J, Koh B, Kobayashi T, Fujisaki J, Clemens T . Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell. 2012; 10(3):259-72. PMC: 3652251. DOI: 10.1016/j.stem.2012.02.003. View